calcium dobesilate has been researched along with Diabetic Glomerulosclerosis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Y; Liu, C; Yu, M | 1 |
| Bollin, R; Haller, H; Menne, J; Njau, F; Schenk, H; Shushakova, N; Wulfmeyer, VC | 1 |
| Bertram, A; Haller, H; Ji, L; Menne, J; Stahl, K | 1 |
| Li, S; Mou, S; Ni, Z; Qi, C; Shao, X; Zhou, Y | 1 |
| Li, S; Liu, J; Sun, D | 1 |
| Cai, T; Dong, JJ; Liao, L; Shang, HX; Wu, XY; Zhang, XQ; Zhang, ZW | 1 |
| Bian, LX; Gao, MJ; Li, B; Li, ML; Liu, M; Yu, GN | 1 |
| Liu, X | 1 |
| Cui, B; Dong, J; Li, M; Liu, S; Liu, X; Xu, Y | 1 |
2 review(s) available for calcium dobesilate and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Molecular Mechanisms and Treatment Strategies in Diabetic Nephropathy: New Avenues for Calcium Dobesilate-Free Radical Scavenger and Growth Factor Inhibition.
Topics: Antioxidants; Calcium Dobesilate; Diabetic Nephropathies; Endothelium; Free Radical Scavengers; Humans; Intercellular Signaling Peptides and Proteins; Oxidative Stress | 2017 |
Calcium Dobesilate and Micro-vascular diseases.
Topics: Animals; Antioxidants; Calcium Dobesilate; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Microvessels; Oxidative Stress; Vascular Diseases | 2019 |
1 trial(s) available for calcium dobesilate and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Diabetic Nephropathy Can Be Treated with Calcium Dobesilate by Alleviating the Chronic Inflammatory State and Improving Endothelial Cell Function.
Topics: Aged; Albuminuria; Anti-Inflammatory Agents; Calcium Dobesilate; Chronic Disease; Creatine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Inflammation; Kidney Function Tests; Male; Middle Aged; Prospective Studies | 2018 |
6 other study(ies) available for calcium dobesilate and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Effects of calcium dobesilate combined with categlicine and valsartan capsules on inflammation and cellular immunity in patients with diabetic nephropathy.
Topics: Calcium Dobesilate; Capsules; Diabetes Mellitus; Diabetic Nephropathies; Humans; Immunity, Cellular; Inflammation; Valsartan | 2023 |
Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice.
Topics: Animals; Binding Sites; Calcium Dobesilate; Cell Movement; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelial Cells; Heparitin Sulfate; Humans; Kinetics; Mice; Mice, Inbred NOD; Protein Binding; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2020 |
Calcium Dobesilate Prevents Diabetic Kidney Disease by Decreasing Bim and Inhibiting Apoptosis of Renal Proximal Tubular Epithelial Cells.
Topics: Apoptosis; Bcl-2-Like Protein 11; Calcium Dobesilate; Cell Line; Diabetic Nephropathies; Epithelial Cells; Glucose; Humans; Kidney Tubules, Proximal | 2017 |
[Protective effect of calcium dobesilate against early diabetic nephropathy of rat kidney].
Topics: Albuminuria; Animals; Blood Glucose; Calcium Dobesilate; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelins; Glycated Hemoglobin; Hemostatics; Kidney Cortex; Male; Matrix Metalloproteinase 9; Plasminogen Activator Inhibitor 1; Random Allocation; Rats; Rats, Wistar | 2009 |
Effect of calcium dobesilate on nephropathy in type 2 diabetic rats.
Topics: Animals; Calcium Dobesilate; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Male; Protein Kinase C; Random Allocation; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Effects of calcium dobesilate on glomerulus TIMP1 and collagen IV of diabetic rats.
Topics: Animals; Calcium Dobesilate; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney Glomerulus; Nephrectomy; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-1 | 2005 |